TABLE 8.

Interaction effects table.

	Control		Vibration
	Contrast	% change	Contrast	% change	Difference compared to vibration group	p-value	95% lower bound	95% upper bound	p-value group*month
DXA Fat mass (g)									p = 0.0107
Month 6 vs. Baseline	268.74	1.01	−47.37	−0.19	−316.11	0.573	−894.894	262.665
Month 12 vs. Baseline	752.91	2.82	−23.16	−0.09	−776.06	0.043	−1535.777	−16.35
Month 18 vs. Baseline	326.41	1.22	267.62	1.07	−58.79	1.000	−846.76	729.182
Lean mass (g)									p = 0.0268
Month 6 vs. Baseline	501.40	1.33	146.61	0.40	−354.79	0.132	−776.399	66.814
Month 12 vs. Baseline	837.14	2.21	318.02	0.86	−519.12	0.009	−936.298	−101.941
Month 18 vs. Baseline	697.33	1.84	415.26	1.13	−282.07	0.390	−728.222	164.085
Body mass (g)									p = 0.0015
Month 6 vs. Baseline	766.60	1.15	98.48	0.15	−668.11	0.121	−1448.131	111.907
Month 12 vs. Baseline	1577.93	2.37	292.20	0.46	−1285.72	0.003	−2223.718	−347.732
Month 18 vs. Baseline	1005.83	1.51	674.80	1.05	−331.03	1.000	−1270.346	608.277
Tibia HR-pQCT Total BMD (mgHA/cm3)									p = 0.0063
Month 6 vs. Baseline	0.64	0.25	−0.46	−0.18	−1.09151	0.272	−2.637	0.454
Month 12 vs. Baseline	−0.81	−0.31	−0.32	−0.13	0.49332	1.000	−1353	2.34
Month 18 vs. Baseline	−0.65	−0.25	−1.67	−0.66	−1.02255	0.686	−3.056	1.011
Trabecular vBMD (mgHA/cm3)									p = 0.0159
Month 6 vs. Baseline	−0.02	−0.01	−0.21	−0.13	−0.18782	1.000	−1.167	0.791
Month 12 vs. Baseline	−1.37	−0.89	−0.25	−0.16	1.11947	0.052	−0.008	2.247
Month 18 vs. Baseline	−1.57	−1.02	−0.99	−0.64	0.58315	0.941	−0.803	1.969
BVTV (%)									p = 0.0231
Month 6 vs. Baseline	0.00	−0.02	−0.00011	−0.09	−0.00009	1.000	−0.001	0.001
Month 12 vs. Baseline	0.00	−0.88	−0.00017	−0.13	0.00096	0.050	0.000	0.002
Month 18 vs. Baseline	0.00	−1.06	−0.00082	−0.64	0.00054	0.825	−0.001	0.002
Serum CTX (pmol/L)									p = 0.0155
Month 6 vs. Baseline	255.47	6.12	203.73	4.85	−51.74	1.000	−468.701	365.225
Month 12 vs. Baseline	87.79	2.10	568.60	13.53	480.8	0.039	17.735	943.873
Month 18 vs. Baseline	397.14	9.51	889.92	21.18	492.78	0.075	−33.247	1018.812